Rep. Josh Gottheimer bought Eli Lilly and Company (LLY)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Sep 12, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Sep 12, 2023
- Disclosed
- Oct 15, 2023
- Days to disclose
- 33
- Asset type
- Stock
- As filed
- Eli Lilly And Company
- Industry
- Drug Manufacturers - General · Healthcare
Other trades in this filing
All of Gottheimer's trades →- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 26, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 26, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 26, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 22, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 22, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 22, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 21, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 18, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (full) Veritex Holdings VBTX
$1K–$15K · Traded Sep 18, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (partial) Veritex Holdings VBTX
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (partial) Fox Factory Holding FOXF
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (full) Novozymes A/S NVZMY
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (full) Verizon Communications VZ
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (full) ENN Energy Holdings Limited XNGSY
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (full) The Shyft Group SHYF
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
- Oct 15, 2023$1K–$15K
Sold (partial) Exact Sciences EXAS
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
Recent Congress trades in LLY
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Aug 24, 2026$1K–$15K
Sen. John Boozman (R-AR)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Nov 21, 2025 · disclosed Aug 24, 2026 · Joint · filed 276 days later
- Aug 10, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Jul 1, 2026 · disclosed Aug 10, 2026
Committee overlap: Energy and Commerce - Aug 10, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Bought Eli Lilly and Company LLY
$1K–$15K · Traded Jan 2, 2026 · disclosed Aug 10, 2026 · filed 220 days later
Committee overlap: Energy and Commerce - Aug 10, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
Sold Eli Lilly and Company LLY
$1K–$15K · Traded Dec 2, 2025 · disclosed Aug 10, 2026 · filed 251 days later
Committee overlap: Energy and Commerce - Aug 5, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
Sold Eli Lilly and Company LLY
$15K–$50K · Traded Apr 15, 2025 · disclosed Aug 5, 2026 · Joint · filed 477 days later
Committee overlap: HELP - Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
Sold (full) Eli Lilly and Company LLY
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jul 20, 2026$1K–$15K
Rep. Dan Newhouse (R-WA-4)
Sold (partial) Eli Lilly and Company LLY
$1K–$15K · Traded Jul 10, 2026 · disclosed Jul 20, 2026 · Spouse
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.